ClinicalTrials.gg
RecruitingNCT06767137SLEEPwindowUpdated Feb 17, 2025

Comparative Efficacy of BRT and CBT-I for Insomnia

An interventional study of Cognitive behavioral therapy for insomnia (CBT-I) and Bedtime restriction (BRT) in Insomnia Disorders, Insomnia Disorder and Insomnia, sponsored by Christoph Nissen. Recruiting at 2 sites in Switzerland. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-02-17.

Sponsored by Christoph Nissen · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
160
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 34 studies in Sleep Initiation and Maintenance Disorders with a site in Switzerland — 8 open to participants now, 9 under way, none of them phase 3. Sleep Initiation and Maintenance Disorders · Switzerland.

Planned enrollment
7th of 27
160 · median 68
Started
2025
with 4 others
No phase
15 of 34
4 open now
Registered
32nd of 34
by date
Lead sponsor
2 of 34
Christoph Nissen

Among the 34 studies in Sleep Initiation and Maintenance Disorders with a site in Switzerland, this one is the 7th largest by planned enrollment of the 27 interventional ones that give a count, is one of 5 that started in 2025, is one of 15 with no phase, and was the 32nd registered.

Sleep Initiation and Maintenance Disorders

2,738 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 735 are open to participants now.

Browse Sleep Initiation and Maintenance Disorders studies →

Open to participants now

8 of the 34 studies in Sleep Initiation and Maintenance Disorders with a site in Switzerland are open now. Recruiting first, the newest first:

2 more — sign in →

All 8 open studies →

A study can be open while its sites in Switzerland have not opened yet or have stopped. Only those recruiting at a site in Switzerland →

Who these studies take

Of the 394 Sleep Initiation and Maintenance Disorders studies recruiting now, 156 (40%) set no upper age limit and 208 (53%) stop at 75 or younger; 61 take children under 18; 112 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 34 studies in Sleep Initiation and Maintenance Disorders with a site in Switzerland, or all of them as a file.
02

Study summary

This study evaluates two behavioral treatments for patients with insomnia disorder: Bedtime Restriction Therapy (BRT) and Cognitive Behavioral Therapy for Insomnia (CBT-I). Both therapies aim to improve the clinical symptomatology of insomnia by teaching participants techniques to better manage their sleep schedule and habits. BRT is a simpler and shorter therapy focused on aligning the time spent in bed with reported sleep time. CBT-I includes additional components such as relaxation techniques and cognitive exercises. The study will compare these treatments to see if BRT is as effective as CBT-I in improving the clinical symptomatology of insomnia.

03

Conditions studied

  • Insomnia Disorders
  • Insomnia Disorder
  • Insomnia
  • Insomnia Chronic
  • Insomnia, Primary
  • Insomnia, Nonorganic
  • Insomnia Type; Sleep Disorder

Keywords

  • insomnia
  • cognitive behavioral therapy
  • bedtime restriction
  • sleep restriction
04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Must meet criteria for insomnia disorder.
  • Adults aged 18 to 80 years
  • Capable of giving written .
  • Sufficient fluency in the study site's language (i.e., German or French) to understand all study-related information.

Exclusion criteria

Exclusion Criteria:

  • Unstable, progressive, or degenerative medical condition
  • Acute pain or poorly managed chronic pain
  • Suicidality
  • Uncontrolled psychiatric condition requiring treatment outside of study
  • Alcohol or drug abuse or dependency
  • Diagnosis of psychosis, bipolar disorder, autism, borderline personality disorder, or antisocial personality disorder
  • Clinical evidence of sleep disorders other than insomnia (e.g., sleep apnea, restless legs, periodic limb movements in sleep, parasomnia)
  • Evidence of intellectual disability
  • Regular intake of benzodiazepines (BZD) or benzodiazepine receptor agonists (BZDRA)
  • Alteration of medication within 4 weeks prior to study treatment or planned alteration during the trial period (stable medication except BZD or BZDRA does not lead to exclusion)
  • Current other psychotherapy for insomnia
  • Known pregnancy or breastfeeding
  • Inability to comply with study procedure
  • Insufficient fluency in German or French to complete the study
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
160 participants (estimated)

Study arms

  • Experimental
    Cognitive behavioral therapy for insomnia (CBT-I)

    Behavioral: Cognitive behavioral therapy for insomnia (CBT-I)

  • Experimental
    Bedtime restriction (BRT)

    Behavioral: Bedtime restriction (BRT)

Interventions

  • BehavioralCognitive behavioral therapy for insomnia (CBT-I)

    Cognitive Behavioral Therapy for Insomnia (CBT-I) is a gold-standard, evidence-based treatment combining techniques to improve the clinical symptomatology of insomnia. Delivered in six 90-minute group sessions over six weeks, it includes: sleep education (i.e. understanding sleep mechanisms and influencing factors), bedtime restriction (i.e. aligning bedtimes with reported sleep duration), stimulus control (i.e. getting out of bed when unable to sleep), cognitive therapy (i.e. addressing dysfunctional sleep beliefs), relaxation techniques (i.e. using methods like progressive muscle relaxation).

  • BehavioralBedtime restriction (BRT)

    Bedtime Restriction Therapy (BRT): A behavioral intervention aimed at improving the clinical symptomatology of insomnia by aligning time spent in bed with reported sleep duration. Participants attend four 60-minute group therapy sessions over six weeks. The intervention includes: setting individualized sleep windows based on sleep diaries, regular adjustment of sleep schedules to enhance sleep pressure, group discussions to address implementation challenges and maintain motivation. BRT focuses exclusively on bed time restriction without additional cognitive or relaxation components, making it a simplified, resource-efficient approach to treating insomnia.

06

What researchers measure

Primary outcomes

  1. Insomnia Severity Index (ISI) summary scores

    Time frame: Baseline (T0) to 6 weeks (T1), 3 months (T2), and 6 months (T3)

07

Study locations

2 of 2 sites recruiting
  • Universität Bern, Psychotherapeutische Praxisstelle
    Bern, 3012, Switzerland
    Recruiting
  • Service des specialités psychiatriques, Hôpitaux universitaires de Genève
    Geneva, 1201, Switzerland
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Mar 2025; primary completion for Nov 2027, 31 months later.

Of 1,219 non-industry interventional studies with no phase under Sleep Initiation and Maintenance Disorders, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 35. This study's planned 31 months is above that.

Counting every sponsor, half of 1,297 studies reached it within 15 months; a quarter within 6 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 6, 2025
First posted
Jan 9, 2025
StartEst.
Mar 10, 2025
Primary completionEst.
Nov 1, 2027
CompletionEst.
Nov 1, 2027
Last update
Feb 17, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 17, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06767137
Lead sponsor
Christoph Nissen
Responsible party
Christoph Nissen (Prof. Dr. med., University of Geneva, Switzerland) — Sponsor-investigator
First posted
Jan 9, 2025
Start date
Mar 10, 2025 (estimated)
Primary completion
Nov 1, 2027 (estimated)
Completion
Nov 1, 2027 (estimated)
Last update
Feb 17, 2025

Study contacts

Elisabeth Hertenstein, PD, PhD
Contact
sleepwindow@unige.ch
+41589440300
Marie Angelillo, MSc
Contact
sleepwindow@unige.ch
+4158 944 03 00

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion